Stephen K. Doberstein, SVP & Chief Scientific Officer at NEKTAR THERAPEUTICS (NKTR), sold 6,922 shares at $31.37 ($217K) on 2019-05-16, disclosed to the SEC on 2019-05-17.
Seasonal sale ($217k) by SVP & Chief Scientific Officer — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.37 | 3,461 | $109K | 50.0% |
| 2 | $31.37 | 3,461 | $109K | 50.0% |
| Total | $31.37 avg | 6,922 | $217K | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $281K | — | Filing → |
| NKTR | SELL | 2018-11-19 | $173K | — | Filing → |
| NKTR | SELL | 2018-05-18 | $573K | — | Filing → |